Perrigo PRGO
NYSE PRGO
$13.85 -0.11 (-0.82%)
At close: Aug 20, 2026 · 12:50 PM UTC

Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026)

Perrigo (PRGO) posted quarterly Liabilities and Shareholders Equity of $8.0 billion for Q1 2026, down 18.2% year-over-year from $9.8 billion in Q1 2025, and down 6.47% quarter-over-quarter from $8.5 billion in Q4 2025.

Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has reported Liabilities and Shareholders Equity for 14 consecutive years, with $8.0 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 18.2% year-over-year to $8.0 billion; the TTM figure through Mar 2026 stood at $36.7 billion (down 10.51% YoY), while the FY2025 annual figure was $8.5 billion, down 11.53% from the prior year.
  • Liabilities and Shareholders Equity declined to $8.0 billion in Q1 2026 per PRGO's latest filing, from $8.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $11.2 billion in Q3 2024 and bottomed at $8.0 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $10.3 billion across 5 years, with a median of $10.6 billion in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity climbed 5.67% — and 2026, when it declined 18.2%.
  • Perrigo's Liabilities and Shareholders Equity stood at $11.0 billion in 2022, then fell by 1.89% to $10.8 billion in 2023, then decreased by 10.74% to $9.6 billion in 2024, then dropped by 11.53% to $8.5 billion in 2025, then fell by 6.47% to $8.0 billion in 2026.
  • Business Quant data shows PRGO's Liabilities and Shareholders Equity at $8.0 billion in Q1 2026, $8.5 billion in Q4 2025, and $10.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - 6.18 Bn
10 Perrigo 1.93 Bn 1.53 Bn 313.90 Mn 7.61 Bn

Historic Data

Download Data
DateValue
Jun 27, 2026 7.61 Bn
Mar 28, 2026 7.98 Bn
Dec 31, 2025 8.54 Bn
Sep 27, 2025 10.08 Bn
Jun 28, 2025 10.09 Bn
Mar 29, 2025 9.76 Bn
Dec 31, 2024 9.65 Bn
Sep 28, 2024 11.20 Bn
Jun 29, 2024 10.40 Bn
Mar 30, 2024 10.64 Bn
Dec 31, 2023 10.81 Bn
Sep 30, 2023 10.76 Bn
Jul 1, 2023 10.96 Bn
Apr 1, 2023 10.95 Bn
Dec 31, 2022 11.02 Bn
Oct 1, 2022 10.68 Bn
Jul 2, 2022 10.92 Bn
Apr 2, 2022 10.39 Bn
Dec 31, 2021 10.43 Bn
Oct 2, 2021 10.92 Bn